ArticleFrontiers in medicine2026
Effects of whole cycle nutrition management based on "Hospital to Home (H2H)" model on nutritional status and immune function of patients with gastrointestinal tumor chemotherapy.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: To evaluate effects of whole-cycle nutrition management based on "Hospital to Home (H2H)" model on nutritional status and immune function in gastric and colorectal cancer patients receiving chemotherapy. Methods: In this randomized controlled trial, 100 gastric or colorectal cancer patients with malnutrition risk (PG-SGA ≥ 2) were randomly assigned to routine nursing (control, Results: The study group showed significantly greater improvements in PG-SGA score (mean difference at cycle 6: -1.4, 95% CI: -1.9 to -0.9, Conclusion: H2H whole-cycle nutrition management improves nutritional status, immune function, fatigue, self-care ability, quality of life, and satisfaction while reducing adverse reactions in gastric and colorectal cancer patients receiving chemotherapy. Larger multicenter studies with long-term follow-up are needed to confirm these findings and assess survival outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.